Humana (HUM)

• Market cap: $35.6B
• 1 day: 0.59%
• 5 days: 3.90%
• 1 month: 13.49%
• 3 months: -17.53%
• 6 months: -16.85%
• Year to date: -37.10%
• 1 year: -41.68%
• 5 years: -12.63%
• 10 years: 116.76%
• Sector: Financials
• Industry: Hospital & Medical Service Plans

About: Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Employees: 67,600

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

16% more call options, than puts

Call options by funds: $2.05B | Put options by funds: $1.76B

3.38% less ownership

Funds ownership: 95.99% [Q2] → 92.61% (-3.38%) [Q3]

5% less funds holding

Funds holding: 960 [Q2] → 909 (-51) [Q3]

15% less repeat investments, than reductions

Existing positions increased: 315 | Existing positions reduced: 371

19% less capital invested

Capital invested by funds: $43.2B [Q2] → $35B (-$8.23B) [Q3]

35% less first-time investments, than exits

New positions opened: 93 | Existing positions closed: 144

44% less funds holding in top 10

Funds holding in top 10: 25 [Q2] → 14 (-11) [Q3]

Research analyst outlook

22 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $247 16% downside
• Avg. target: $289 2% downside
• High target: $400 35% upside

22 analyst ratings

• positive: 5 23%
• neutral: 16 73%
• negative: 1 5%

B of A Securities Kevin Fischbeck 70% 1-year accuracy 7 / 10 met price target	4% upside $308	Neutral Upgraded	6 Nov 2024
TD Cowen Gary Taylor 38% 1-year accuracy 5 / 13 met price target	9% downside $268	Hold Maintained	4 Nov 2024
Wells Fargo Stephen Baxter 15% 1-year accuracy 3 / 20 met price target	2% downside $290	Overweight Maintained	4 Nov 2024
Barclays Andrew Mok 44% 1-year accuracy 24 / 55 met price target	14% downside $253	Equal-Weight Maintained	31 Oct 2024
Truist Securities David Macdonald 44% 1-year accuracy 18 / 41 met price target	12% downside $260	Hold Maintained	11 Oct 2024